Ticker Details
BioAge Labs, Inc.
IPO Date:	September 26, 2024
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$856.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.34 | 3.36%
Avg Daily Range (30 D):	$0.76 | 3.95%
Avg Daily Range (90 D):	$0.47 | 3.40%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	.76M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	124
Avg Institutional Trade:	$1.42M
Avg Institutional Trade (30 D):	$1.14M
Avg Institutional Trade (90 D):	$1.39M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.35M
Avg Closing Trade (30 D):	$.93M
Avg Closing Trade (90 D):	$1.12M
Avg Closing Volume:	136.22K

News

Jan 22, 2026 @ 3:30 AM BioAge Announces Pricing of Upsized $115.0 Million... Source: Not Specified

Jan 20, 2026 @ 9:01 PM BioAge Announces Proposed Public Offering Source: Globe Newswire

Jan 20, 2026 @ 2:00 PM BioAge Announces Indication Expansion for Oral NLR... Source: Bioage Labs, Inc.

Dec 13, 2025 @ 3:15 PM 2 Reasons I Wouldn't Touch BioAge Labs Stock With ... Source: Prosper Junior Bakiny

Nov 18, 2025 @ 6:02 PM Top 3 Biotech Stocks Capitalizing on the AI Revolu... Source: Timothy Fries

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$13.61	$-.56	$-.6
Diluted EPS	$13.61	$-.56	$-.6
Revenue	$5.92M	$2.05M	$2.41M
Gross Profit
Net Income / Loss	$-75.79M	$-20.17M	$-21.56M
Operating Income / Loss	$-89.72M	$-23.14M	$-24.77M
Cost of Revenue
Net Cash Flow	$-118.97M	$-4.75M	$-37.11M
PE Ratio	1.62